Authors

    Language

    English

    Publication Date

    1-1-2023

    Journal

    Methods in Enzymology

    DOI

    10.1016/bs.mie.2022.11.001

    PMID

    36764757

    PMCID

    PMC11102804

    PubMedCentral® Posted Date

    5-19-2024

    PubMedCentral® Full Text Version

    Author MSS

    Abstract

    In recent years, Proteolysis Targeting Chimera (PROTAC) technology has emerged as one of the most promising approaches to remove disease-associated proteins by utilizing cells' own destruction machinery. To achieve successful degradation of a protein of interest (POI), the heterobifunctional PROTAC molecules must penetrate into the cells first, followed by target engagement and formation of the POI-PROTAC-E3 ligase complex. Based on this understanding, the assessment of cell permeability and in cell target engagement are of great importance to evaluate the efficacy of PROTAC candidates. PROTAC molecules can be classified as non-covalent and covalent, and covalent PROTACs can be further divided into irreversible and reversible covalent. Here, we present a high-throughput assay to prioritize different types of BTK PROTACs by measuring their intracellular accumulation quantitatively, using kinase binding assays and the NanoBRET target engagement platform.

    Keywords

    Proteolysis, Proteins, Ubiquitin-Protein Ligases, PROTAC, Target Engagement, Nano-BRET, Binding Constant, Relative Intracellular Accumulation Coefficient

    Published Open-Access

    yes

    Share

    COinS
     
     

    To view the content in your browser, please download Adobe Reader or, alternately,
    you may Download the file to your hard drive.

    NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.